Coutts, A.S. and La Thangue, N.B. (2005) The p53 response: Emerging levels of co-factor complexity. Biochemical and Biophysical Research Communications, 331, pp. 778-785. (doi: 10.1016/j.bbrc.2005.03.150)

Logan, N., Graham, A., Zhao, X., Fisher, R., Maiti, B., Leone, G. and La Thangue, N. B. (2005) E2F-8: an E2F family member with a similar organization of DNA-binding domains to E2F-7. Oncogene, 24(31), pp. 5000-5004. (doi: 10.1038/sj.onc.1208703) (PMID:15897886)

Demonacos, C., Jansson, M., Krstic-Demonacos, M., La Thangue, N.B., O'Connor, D.P., Smith, L. and Xu, D.M. (2004) A new effector pathway links ATM kinase with the DNA damage response. Nature Cell Biology, 6(10), 968-+. (doi: 10.1038/ncb1170)

La Thangue, N.B. (2004) Histone deacetylase inhibitors and cancer therapy. Journal of Chemotherapy, 16, pp. 64-67.

Stevens, C. and La Thangue, N.B. (2004) The emerging role of E2F-1 in the DNA damage response and checkpoint control. DNA Repair, 3, pp. 1071-1079. (doi: 10.1016/j.dnarep.2004.03.034)

McLaughlin, F. and La Thangue, N.B. (2004) Histone deacetylase inhibitors open new doors in cancer therapy. Biochemical Pharmacology, 68, pp. 1139-1144. (doi: 10.1016/j.bcp.2004.05.034)